Elevated Levels of Plasma Collagen Triple Helix Repeat Containing 1 (CTHRC1) Are Strongly Associated with eGFR and

Yeldar Baiken1,2,3, Zhannur Markhametova4, Assem Ashimova1,2

  • 1School of Engineering and Digital Sciences, Nazarbayev University, Astana 010000, Kazakhstan.

Insights

Collagen triple helix repeat containing 1 (CTHRC1) shows promise as a novel blood biomarker for chronic kidney disease (CKD). Elevated plasma CTHRC1 levels significantly differentiate CKD patients from healthy individuals.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Clinical Chemistry

Background:

  • Chronic kidney disease (CKD) presents complex pathophysiology with diverse etiologies.
  • Key indicators of CKD include elevated plasma creatinine, proteinuria, albuminuria, and reduced estimated glomerular filtration rate (eGFR).
  • Existing biomarkers for CKD progression are limited, necessitating the search for novel diagnostic tools.

Purpose of the Study:

  • To investigate the potential of collagen triple helix repeat containing 1 (CTHRC1) as a blood biomarker for CKD.
  • To evaluate the correlation of CTHRC1 levels with established clinical markers of kidney function.
  • To determine if plasma CTHRC1 levels can differentiate between CKD patients and healthy controls.

Main Methods:

  • Study included 26 CKD patients and 18 healthy controls.
  • Collected clinical characteristics, complete blood counts, and biochemical analyses.
  • Utilized human ELISA kits to quantify plasma CTHRC1 levels and other potential biomarkers.

Main Results:

  • Plasma CTHRC1 levels showed a significant correlation with 24-hour urine total protein, creatinine, urea, and uric acid.
  • A highly significant difference (p ≤ 0.0001) in CTHRC1 levels was observed between the CKD group and the control group.
  • CTHRC1 levels were found to be significantly elevated in CKD patients compared to healthy individuals.

Conclusions:

  • Plasma CTHRC1 levels can effectively distinguish individuals with CKD from healthy subjects.
  • CTHRC1 emerges as a potential diagnostic biomarker for CKD.
  • Further research with larger, diverse patient cohorts is warranted to validate these findings and explore clinical utility.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
49
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
57
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
47
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.9K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11